Minaxi Jhawer is an Oncology physician affiliated with Englewood Hospital and Medical Center. OpenAlex indexes 68 publications with 2,462 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
350 Engle St
Berrie Building, 1st Floor
Englewood, NJ 076311808
Telephone
201-568-5250Registry record last updated 29 Sept 2009.
Industry payments
57 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- TAIHO ONCOLOGY, INC.Program year20254 payments
- E.R. Squibb & Sons, L.L.C.Program year202512 payments
- Merck Sharp & Dohme LLCProgram year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
42.6%Antidiarrheal microorganisms31.5%Creon56%Folic Acid44%Part D<11 patientsVitamin B1211.1%Cyanocobalamin Injection100%Part D<11 patientsBlood & clotting
42.6%Factor Xa inhibitor42.6%Xarelto61%Eliquis39%Part D<11 patientsCancer & immunology
14.8%Aromatase Inhibitor14.8%Anastrozole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update
Journal of Clinical Oncology
2026 - Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update
Journal of Clinical Oncology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Aryeh Shander, MD
Englewood Hospital and Medical Center
Kurt Wengerter, MD
Englewood Hospital and Medical Center
Ramin Hastings, MD
Englewood Hospital and Medical Center
Cherif Boutros, MD
Englewood Hospital and Medical Center
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”